Prooxidant-induced glutathione antioxidant response in vitro and in vivo: A comparative study between schisandrin B and curcumin

Biological and Pharmaceutical Bulletin

Volumn 35, Issue 4, 2012, Pages 464-472

  Leong, Pou Kuan ^a   Chiu, Po Yee ^a   Ko, Kam Ming ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

Curcumin; Glutathione antioxidant response; Hepatoprotection; Hormesis; Oxidative stress; Schisandrin B

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; CURCUMIN; CYTOCHROME; GLUTATHIONE; MENADIONE; REACTIVE OXYGEN METABOLITE; SCHIZANDRIN B; SUCCINATE DEHYDROGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL PROTECTION; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG BIOAVAILABILITY; DRUG EXPOSURE; DRUG POTENCY; ENZYME ACTIVITY; FEMALE; GLUTATHIONE METABOLISM; IN VITRO STUDY; IN VIVO STUDY; LIVER MICROSOME; LIVER PROTECTION; LIVER TOXICITY; LONG TERM EXPOSURE; LOW DRUG DOSE; MOUSE; NONHUMAN; SINGLE DRUG DOSE;

ANIMALS; ANTIOXIDANTS; CARBON TETRACHLORIDE POISONING; CELL LINE; CURCUMIN; CYCLOOCTANES; FEMALE; GLUTATHIONE; LIGNANS; LIVER; MICE; MICE, INBRED BALB C; MICE, INBRED ICR; MICROSOMES, LIVER; POLYCYCLIC COMPOUNDS; REACTIVE OXYGEN SPECIES; VITAMIN E; VITAMIN K 3;

EID: 84859451739     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.35.464     Document Type: Article

References (39)

1. Ballatori N, Krance SM, Notenboom S, Shi S, Tieu K, Hammond CL. Glutathione dysregulation and the etiology and progression of human diseases. Biol. Chem., 390, 191-214 (2009).
2. Chen N, Chiu PY, Ko KM. Schisandrin B enhances cerebral mitochondrial antioxidant status and structural integrity, and protects against cerebral ischemia/reperfusion injury in rats. Biol. Pharm. Bull., 31, 1387-1391 (2008).
3. Chiu PY, Ko KM. Time-dependent enhancement in mitochondrial glutathione status and ATP generation capacity by schisandrin B treatment decreases the susceptibility of rat hearts to ischemia-reperfusion injury. Biofactors, 19, 43-51 (2003).
4. Chiu PY, Leung HY, Ko KM. Schisandrin B enhances renal mitochondrial antioxidant status, functional and structural integrity, and protects against gentamicin-induced nephrotoxicity in rats. Biol. Pharm. Bull., 31, 602-605 (2008).
5. Chiu PY, Tang MH, Mak DH, Poon MK, Ko KM. Hepatoprotective mechanism of schisandrin B: role of mitochondrial glutathione antioxidant status and heat shock proteins. Free Radic. Biol. Med., 35, 368-380 (2003).
6. Lam PY, Yan CW, Chiu PY, Leung HY, Ko KM. Schisandrin B protects against solar irradiation-induced oxidative stress in rat skin tissue. Fitoterapia, 82, 393-400 (2011).
7. Williams KJ, Fisher EA. Oxidation, lipoproteins, and atherosclerosis: which is wrong, the antioxidants or the theory? Curr. Opin. Clin. Nutr. Metab. Care, 8, 139-146 (2005).
8. Eder K, Flader D, Hirche F, Brandsch C. Excess dietary vitamin E lowers the activities of antioxidative enzymes in erythrocytes of rats fed salmon oil. J. Nutr., 132, 3400-3404 (2002).
9. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet, 347, 781-786 (1996).
10. D'Autréaux B, Toledano MB. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat. Rev. Mol. Cell Biol., 8, 813-824 (2007).
11. Zhang Q, Pi J, Woods CG, Andersen ME. A systems biology perspective on Nrf2-mediated antioxidant response. Toxicol. Appl. Pharmacol., 244, 84-97 (2010).
12. Tapia PC. Sublethal mitochondrial stress with an attendant stoichiometric augmentation of reactive oxygen species may precipitate many of the beneficial alterations in cellular physiology produced by caloric restriction, intermittent fasting, exercise and dietary phytonutrients: "Mitohormesis" for health and vitality. Med. Hypotheses, 66, 832-843 (2006).
13. Lewis KN, Mele J, Hayes JD, Buffenstein R. Nrf2, a guardian of healthspan and gatekeeper of species longevity. Integr. Comp. Biol., 50, 829-843 (2010).
14. Weinberg RJ, Hancke JL, Burgos RA, Ahumada F. Schisandra chinensis (TURCZ.) BAILL. Fitoterapia, 70, 451-471 (1999).
15. Chiu PY, Leung HY, Siu AH, Poon MK, Ko KM. Schisandrin B decreases the sensitivity of mitochondria to calcium ion-induced permeability transition and protects against carbon tetrachloride toxicity in mouse livers. Biol. Pharm. Bull., 30, 1108-1112 (2007).
16. Chiu PY, Leung HY, Siu AH, Poon MK, Ko KM. Schisandrin B decreases the sensitivity of mitochondria to calcium ion-induced permeability transition and protects against ischemia-reperfusion injury in rat hearts. Acta Pharmacol. Sin., 28, 1559-1565 (2007).
17. 2+-induced mitochondrial permeability transition and mitochondrial membrane potential in AML12 hepatocytes. Phytother. Res., 23, 1592-1602 (2009).
18. Chiu PY, Mak DHF, Poon MK, Ko KM. Role of cytochrome P-450 in schisandrin B-induced antioxidant and heat shock responses in mouse liver. Life Sci., 77, 2887-2895 (2005).
19. Chiu PY, Leung HY, Poon MK, Lee SST, Ko KM. Schisandrin B induced antioxidant response is partly mediated by cytochrome P-4502E1 catalyzed reaction in mouse liver. Mol. Cell. Biochem., 293, 87-92 (2006).
20. Leong PK, Chiu PY, Chen N, Leung H, Ko KM. Schisandrin B elicits a glutathione antioxidant response and protects against apoptosis via the redox-sensitive ERK/Nrf2 pathway in AML12 hepatocytes. Free Radic. Res., 45, 483-495 (2011).
21. Reddy ACP, Lokesh BR. Alterations in lipid peroxides in rat liver by dietary n-3 fatty acids: modulation of antioxidant enzymes by curcumin, eugenol, and vitamin E. J. Nutr. Biochem., 5, 181-188 (1994).
22. Park EJ, Jeon CH, Ko G, Kim J, Sohn DH. Protective effect of curcumin in rat liver injury induced by carbon tetrachloride. J. Pharm. Pharmacol., 52, 437-440 (2000).
23. Shapiro H, Ashkenazi M, Weizman N, Shahmurov M, Aeed H, Bruck R. Curcumin ameliorates acute thioacetamide-induced hepatotoxicity. J. Gastroenterol. Hepatol., 21, 358-366 (2006).
24. Bruck R, Ashkenazi M, Weiss S, Goldiner I, Shapiro H, Aeed H, Genina O, Helpern Z, Pines M. Prevention of liver cirrhosis in rats by curcumin. Liver Int., 27, 373-383 (2007).
25. Reyes-Gordillo K, Segovia J, Shibayama M, Tsutsumi V, Vergara P, Moreno MG, Muriel P. Curcumin prevents and reverses cirrhosis induced by bile duct obstruction or CCl4 in rats: role of TGF-beta modulation and oxidative stress. Fundam. Clin. Pharmacol., 22, 417-427 (2008).
26. McNally SJ, Harrison EM, Ross JA, Garden OJ, Wigmore SJ. Curcumin induces heme oxygenase 1 through generation of reactive oxygen species, p38 activation and phosphatase inhibition. Int. J. Mol. Med., 19, 165-172 (2007).
27. Thor H, Smith MT, Hartzell P, Bellomo G, Jewell SA, Orrenius S. The metabolism of menadione (2-methyl-1,4-naphthoquinone) by isolated hepatocytes. A study of the implications of oxidative stress in intact cells. J. Biol. Chem., 257, 12419-12425 (1982).
28. Wu JC, Merlino G, Fausto N. Establishment and characterization of differentiated, nontransformed hepatocyte cell lines derived from mice transgenic for transforming growth factor alpha. Proc. Natl. Acad. Sci. U.S.A., 91, 674-678 (1994).
29. Griffith OW. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal. Biochem., 106, 207-212 (1980).
30. Chiu PY, Leung HY, Poon MK, Mak DH, Ko KM. Effects of schisandrin B enantiomers on cellular glutathione and menadione toxicity in AML12 hepatocytes. Pharmacology, 77, 63-70 (2006).
31. Donato MT, Castell JV. Strategies and molecular probes to investigate the role of cytochrome P450 in drug metabolism: focus on in vitro studies. Clin. Pharmacokinet., 42, 153-178 (2003).
32. Dinkova-Kostova AT, Talalay P. Direct and indirect antioxidant properties of inducers of cytoprotective proteins. Mol. Nutr. Food Res., 52 (Suppl 1), S128-S138 (2008).
33. Hao H, Wang G, Cui N, Li J, Xie L, Ding Z. Identification of a novel intestinal first pass metabolic pathway: NQO1 mediated quinone reduction and subsequent glucuronidation. Curr. Drug Metab., 8, 137-149 (2007).
34. Goodman LS, Gilman A. The Pharmacological Basis of Therapeutics. 5th ed., Macmillan Publishing Co., Inc., New York (1975).
35. Chen XM, Li JS, Li W, Han L, Liu XH, Di LQ, Cai BC. Intestinal absorption of the effective components of Schisandra chinensis BAILL by rats single-pass perfusion in situ. Yao Xue Xue Bao, 45, 652-658 (2010).
36. Chang HM, But PPH. Pharmacology and Applications of Chinese Materia Medica. Vol. I, World Scientific Publishing, Singapore (1986).
37. Ko KM, Chen N, Leung HY, Leong EP, Poon MK, Chiu PY. Long-term schisandrin B treatment mitigates age-related impairments in mitochondrial antioxidant status and functional ability in various tissues, and improves the survival of aging C57BL/6J mice. Biofactors, 34, 331-342 (2008).
38. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol. Pharm., 4, 807-818 (2007).
39. Long DJ 2nd, Gaikwad A, Multani A, Pathak S, Montgomery CA, Gonzalez FJ, Jaiswal AK. Disruption of the NAD(P)H : quinone oxidoreductase 1 (NQO1) gene in mice causes myelogenous hyperplasia. Cancer Res., 62, 3030-3036 (2002).